Cargando…
Cooperation of DLC1 and CDK6 Affects Breast Cancer Clinical Outcome
Low DLC1 expression is found to frequently co-occur with aberrant expression of cell cycle genes including CDK6 in human lung and colon cancer. Here, we explore the influence of the synergistic effect of DLC1 and CDK6 on human breast cancer survival at the genetic, transcriptional, and translational...
Autores principales: | Dai, Xiaofeng, Li, Lu, Liu, Xiuxia, Hu, Weiguo, Yang, Yankun, Bai, Zhonghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Genetics Society of America
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291472/ https://www.ncbi.nlm.nih.gov/pubmed/25425654 http://dx.doi.org/10.1534/g3.114.014894 |
Ejemplares similares
-
WDR5 Expression Is Prognostic of Breast Cancer Outcome
por: Dai, Xiaofeng, et al.
Publicado: (2015) -
CDK5 opens the way for DLC1
por: Short, Ben
Publicado: (2014) -
CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014) -
Transcriptome and Multivariable Data Analysis of Corynebacterium glutamicum under Different Dissolved Oxygen Conditions in Bioreactors
por: Sun, Yang, et al.
Publicado: (2016) -
Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas
por: Bujko, M., et al.
Publicado: (2016)